About CollimateHealth
CollimateHealth is the result of outstanding science developed by exceptional researchers. The company was launched as a venture-building project of VP Venture Partners and co-founded by Prof. Dr. Stefan Bartzsch (Chief Scientific Officer), Dr. Johanna Winter (Chief Technology Officer), and Dr. Hans Maria Heÿn (Chief Executive Officer).
The technical team, shown in the image above, has spent nearly a decade developing the company’s core microbeam technology. CollimateHealth has been supported by UnternehmerTUM, TUM Venture Lab Healthcare, Bio-M, and Medical Valley, and has received multiple innovation recognitions.
The underlying technology has been advanced in collaboration with leading academic and clinical institutions, including the Technical University of Munich (TUM), TUM University Hospital Rechts der Isar, Johannes Gutenberg University Mainz, Helmholtz Institute Mainz, Forschungszentrum Jülich, the Institute of Cancer Research, and The Royal Marsden Hospital in London.
Advertisement
